Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Piramal Enterprises

Piramal Enterprises

BSE: 500302|NSE: PEL|ISIN: INE140A01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 10, 16:00
1449.20
2.8 (0.19%)
VOLUME 55,584
LIVE
NSE
Jul 10, 16:05
1448.85
2.45 (0.17%)
VOLUME 869,140
News on Piramal Enterprises
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Broker bullish on Nicholas Piramal

3.27 pm | 30 Dec 2005

Broking house, Edelweiss Securities is bullish on Nicholas Piramal India, NPIL. It has reiterated a value buy rating on the company....

Buy Nicholas Piramal at Rs 240, says Gaba

3.21 pm | 28 Dec 2005

Technical Analyst, Prakash Gaba feels that Nicholas Piramal is good investment buy at Rs 240....

Stay invested in Nicholas Piramal, says Shastri

2.58 pm | 28 Dec 2005

VVLN Shastri of Firstcall India Equity Advisor feels that investors should stay invested in Nicholas Piramal....

Nicholas Piramal has resistance at Rs 290-300

4.07 pm | 25 Nov 2005

Technical Analyst, Salil Sharma, feels that Nicholas Piramal has resistance at Rs 290-300....

Nicholas Piramal better in pharma pack: Irani

3.52 pm | 25 Nov 2005

Mehraboon Irani of Darashaw & Company feels that Nicholas Piramal is one of the better stock in pharma pack....

Nicholas Piramal gets value buy rating: Broker

2.45 pm | 25 Nov 2005

Broking house, Edelweiss Securities is bullish on Nicholas Piramal, NPIL. It has maintained a value buy rating on the company. ...

Nicholas Piramal a good stock to hold, says Vijay

10.31 am | 25 Nov 2005

Investment advisor, PN Vijay, feels that Nicholas Piramal is a good stock to hold....

Nicholas Piramal wins 10 yr custom mfg order

10.42 am | 24 Nov 2005

Nicholas Piramal has won a 10-year custom manufacturing order, and it expects a revenue of USD12-15 million per year, from this order....

New ED - Custom Manufacturing for NPIL

12.38 pm | 16 Nov 2005

NPIL has just announced that Mr Michael J Fernandes will be joining as Executive Director - Custom Manufacturing Group from 1 December 2005 . This is ...

Nicholas Piramal in talks for licensing Relenza

9.33 pm | 14 Nov 2005

Drug major Nicholas Piramal has begun talks with British pharma giant, GlaxoSmithKline for licensing the Avian Flu drug, Zenamavir, branded Relenza....

Nicholas Piramal has resistance at Rs 272-285

2.38 pm | 10 Nov 2005

Technical analyst, Vidur Pendharkar, feels that Nicholas Piramal has a major resistance at Rs 272-285....

Don't invest in Nicholas Piramal at current levels: Pal

2.38 pm | 10 Nov 2005

Surjit Pal of KJMC Financial Services, is of the view that investors should not invest in Nicholas Piramal at current levels....

Exit from Nicholas Piramal, says Chavan

2.14 pm | 09 Nov 2005

Technical analyst, Sachin Chavan, is of the view that one should exit from Nicholas Piramal....

Prefer Ranbaxy Labs to Natco Pharma, says Mehta

10.09 am | 07 Nov 2005

Darshan Mehta of Anagram Stock Broking, feels that one should prefer Ranbaxy Labs to Natco Pharma....

Nicholas Piramal a value buy, says broker

4.17 pm | 28 Oct 2005

Broking house, Edelweiss Securities is bullish on Nicholas Piramal, NPIL. It has reiterated a 'value buy' rating on the company. ...

Nicholas Piramal's strategy to go global

8.38 pm | 27 Oct 2005

Mergers and acquisitions just do not stop for drug maker Nicholas Piramal. The company has acquired UK based Avecia Pharmaceuticals for around 9 milli...

NATCOs unit gets FDA approval

11.28 am | 27 Oct 2005

NATCOs unit gets FDA approval...

Nicholas Piramal acquires UK's Avecia Pharma

11.07 am | 27 Oct 2005

Nicholas Piramal has acquired UK-based Avecia Pharma for 9.5 million pounds. Avecia Pharma has revenues of 36 million pounds. ...

Nicholas Piramal can give 25-30% from current levels

11.41 am | 21 Oct 2005

Ambareesh Baliga of Karvy Stock Broking feels that one can expect 25-30% return in Nicholas Piramal from current levels....

Nicholas Piramal hopes for 15% growth in domestic market

7.46 pm | 20 Oct 2005

Nicholas Piramal came out with its quarterly results on Thursday. The company's operating income and profit are flat in this quarter due to sale of it...

1 2 3
Quick Links for Piramal Enterprises
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.